BIOLOGICAL NEMATICIDE CONTAINING NATURALLY

Brand Owner (click to sort) Address Description
NEMACLEAN CERTIS U.S.A. 9145 Guilford Road, Suite 175 Columbia MD 21046 Biological nematicide containing a naturally occurring fungus for use in controlling plant parasitic nematodes; biocide; germicide; bactericide; virucide; fungicide; insecticide; pesticide; herbicide;Chemicals for use in agriculture except fungicides, herbicides, insecticides and parasiticides; chemicals for the treatment of soil being soil conditioning preparations; Soil additives; Soil improving preparations; Substances for regulating plant growth; Preparations for fortifying plants; Plant nutrients; Chemical preparations for preventing pathogenic infections in plants; biological plant fertilizers and nutrients; microbes for use in the manufacture of nutrients for preventing pathogenic infections in plants;
NEMAGARD CERTIS U.S.A. 9145 Guilford Road, Suite 175 Columbia MD 21046 Biological nematicide containing a naturally occurring fungus for use in controlling plant parasitic nematodes; biocide; germicide; bactericide; virucide; fungicide; insecticide; pesticide; herbicide;Chemicals for use in agriculture except fungicides, herbicides, insecticides and parasiticides; chemicals for the treatment of soil being soil conditioning preparations; Soil additives; Soil improving preparations; Substances for regulating plant growth; Preparations for fortifying plants; Plant nutrients; Chemical preparations for preventing pathogenic infections in plants; biological plant fertilizers and nutrients; microbes for use in the manufacture of nutrients for preventing pathogenic infections in plants;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The synthesis and biological activity of indoloazepines and acid amine salts thereof which are structurally related to naturally-occurring hymenialdisine is disclosed. Naturally-occurring hymenialdisine obtained from the sponge is a potent inhibitor of production of cytokines interleukin-2 (IL-2) and tumor necrosis factor-? (TNF-?). The chemically-synthesized indoloazepines of the invention also inhibit production of IL-2 and TNF-?. The indoloazepines are useful for treating inflammatory diseases, particularly diseases associated with kinases NF-?B or GSK-3? activation or NF-?B activated gene expression products. The indoloazepines are useful for the treatment of cancer by the inhibition of kinases CHK1 and CHK2.